Insurance and Magazine - Pharmacy Technician Pulse

Humana lawsuit exposes fraud risk in high-growth telehealth market

pharmaphorum

AUGUST 26, 2020

Health insurer Humana has filed a lawsuit against telemedicine company QuivvyTech that it says resulted in fraudulent prescriptions worth millions of dollars being written for duped customers.

Insurance

Bharat Biotech acquires licence for GSK’s Shigella vaccine development

Pharmaceutical Technology

JUNE 13, 2025

Can pharma tariffs “Make America Manufacture Again”? Give your business an edge with our leading industry insights.

Vaccines

Vaccines Communication Hospitals Packaging

RFK Jr looks to alter rare disease regulation by fast-tracking drug approvals

Pharmaceutical Technology

JUNE 6, 2025

In one of the fierier remarks from the roundtable, RFK Jr said: “At every level, doctors, other providers, our hospitals, the pharmaceutical companies, the insurance companies, all make money by keeping us sick. Can pharma tariffs “Make America Manufacture Again”? Give your business an edge with our leading industry insights.

Humana lawsuit exposes fraud risk in high-growth telehealth market

Bharat Biotech acquires licence for GSK’s Shigella vaccine development

Trending Sources

RFK Jr looks to alter rare disease regulation by fast-tracking drug approvals

FDA approves Sanofi and Regeneron’s Dupixent for bullous pemphigoid

Vutrisiran marks first silencer approved for ATTR-CM

Revolution Medicines partners Royalty Pharma on $2bn funding

EC approves argenx’s efgartigimod alfa for CIDP treatment

5 HIPAA Compliance Tips For Healthcare Professionals

Mosanna Therapeutics gains $80m to advance OSA nasal spray

Patient-Centric Marketing in the Life Science Industry: Putting the Focus on Patient Needs

5 Social Security Benefits Facts You Might Not Know

Juvenescence enhances AI drug discovery with Ro5 acquisition

EC authorises Sydnexis’ paediatric myopia treatment

MSD receives FDA approval for Enflonsia to prevent RSV

DoH – Abu Dhabi and Sanofi link for vaccine development

SCHOTT Pharma invests in RTU cartridge capacity expansion

Draig secures $140m for neuropsychiatric disorder therapies

Tisento’s MELAS treatment receives fast track status from FDA

European pharma needs scalable models to succeed in US

FDA approves YolTech’s YOLT-101 for familial hypercholesterolemia

CNS innovator oligonucleotide licensing value up 339% from £2bn in 2024

Navamedic signs agreement to acquire dne pharma

Actio gains $66m to advance small molecule therapeutics pipeline

Gilead eyes Kymera’s ‘adhesive’ cancer drug in $750m deal

Eli Lilly and Eisai’s Alzheimer’s drugs denied NHS use due to high costs

Harbour BioMed partners Otsuka on new T-cell therapy

GE HealthCare’s PET imaging agent gains Alzheimer’s label expansion

Zambon gains Chinese regulatory authority approval for Fluimucil IV

Lisata collaborates with GATC Health on drug development

Novo Nordisk signs $812m research deal with Deep Apple for non-GLP-1 drugs

Medera and Novoheart collaborate on mini-heart models for HLHS

Genomics to roll out predictive clinical test across UK

BioOrbit eyes 2026 for pre-clinical trials of space manufactured protein crystals

Novo Nordisk seeks digital health partners to boost GLP-1RA weight loss outcomes

Aytu BioPharma to commercialise Exxua for MDD in the US

Bayer’s Eylea market grip set to slip as Alvotech biosimilar closes in

Alzheimer’s R&D resurgence driven by $16.8bn in acquisitions in 2025YTD

European biotech ecosystem takes aim at changing the funding narrative

Hims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug

The European Market Access Lag: 2021–2024

NHS England chair suggests England can learn from European health schemes

Navigating uncertainty: the future of vaccine oversight amid CDC firings

How will RFK Jr’s American dream for vaccines play out?

Enterome to advance EO2463 immunotherapy with $19m funding

Stay Connected